References
- Hernandez Arroyo J, Izquierdo-Condoy JS, Ortiz-Prado E. A case series and literature review of telogen effluvium and alopecia universalis after the administration of a heterologous COVID-19 vaccine scheme. Vaccines (Basel) 2023;11:444.
- Macklis P, Porter C, Feldman S. A case of late-onset alopecia areata. J Drugs Dermatol 2022;21:420-1.
- Richardson CT, Hayden MS, Gilmore ES, Poligone B. Evaluation of the relationship between alopecia areata and viral antigen exposure. Am J Clin Dermatol 2018;19:119-26. https://doi.org/10.1007/s40257-017-0312-y
- Chu CH, Cheng YP, Chan JY. Alopecia areata after vaccination: recurrence with rechallenge. Pediatr Dermatol 2016;33:e218-9. https://doi.org/10.1111/pde.12849
- Zhao H, Li P, Bian L, et al. Immune response of inactivated rabies vaccine inoculated via intraperitoneal, intramuscular, subcutaneous and needle-free injection technologybased intradermal routes in mice. Int J Mol Sci 2023;24:13587.
- Ahn D, Kim H, Lee B, Hahm DH. Psychological stress-induced pathogenesis of alopecia areata: autoimmune and apoptotic pathways. Int J Mol Sci 2023;24:11711.
- Herve C, Laupeze B, Del Giudice G, Didierlaurent AM, Tavares Da Silva F. The how's and what's of vaccine reactogenicity. NPJ Vaccines 2019;4:39.
- Opel DJ, Omer SB. Measles, mandates, and making vaccination the default option. JAMA Pediatr 2015;169:303-4. https://doi.org/10.1001/jamapediatrics.2015.0291
- Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: part II. Treatment. J Am Acad Dermatol 2010;62:191-202. https://doi.org/10.1016/j.jaad.2009.10.031